Inactive Ingredient Search for Approved Drug Products
Search Names Beginning with T
Inactive Ingredient | Route | Dosage Form | CAS Number | UNII | Maximum Potency per unit dose | Maximum Daily Exposure (MDE) | Record Updated |
---|---|---|---|---|---|---|---|
TAGATOSE | ORAL | SOLUTION | 87810 | T7A20Y888Y | 200mg/15ml | ||
TAGATOSE | RECTAL | SOLUTION | 87810 | T7A20Y888Y | 1.33%w/v | ||
TALC | BUCCAL | GUM, CHEWING | 14807966 | 7SEV7J4R1U | NA | ||
TALC | BUCCAL | TABLET | 14807966 | 7SEV7J4R1U | 15mg | ||
TALC | ORAL | CAPSULE | 14807966 | 7SEV7J4R1U | 729mg | ||
TALC | ORAL | CAPSULE, COATED | 14807966 | 7SEV7J4R1U | 87mg | ||
TALC | ORAL | CAPSULE, COATED PELLETS | 14807966 | 7SEV7J4R1U | 14mg | ||
TALC | ORAL | CAPSULE, COATED, EXTENDED RELEASE | 14807966 | 7SEV7J4R1U | 20mg | ||
TALC | ORAL | CAPSULE, DELAYED RELEASE | 14807966 | 7SEV7J4R1U | 420mg | ||
TALC | ORAL | CAPSULE, EXTENDED RELEASE | 14807966 | 7SEV7J4R1U | 5119mg | ||
TALC | ORAL | DROPS | 14807966 | 7SEV7J4R1U | NA | ||
TALC | ORAL | ELIXIR | 14807966 | 7SEV7J4R1U | 4.5mg/5ml | ||
TALC | ORAL | GRANULE | 14807966 | 7SEV7J4R1U | 322mg | ||
TALC | ORAL | GRANULE, DELAYED RELEASE | 14807966 | 7SEV7J4R1U | 525mg | ||
TALC | ORAL | GRANULE, FOR SUSPENSION | 14807966 | 7SEV7J4R1U | 189mg | ||
TALC | ORAL | LOZENGE | 14807966 | 7SEV7J4R1U | 50mg | ||
TALC | ORAL | PELLET | 14807966 | 7SEV7J4R1U | 69mg | ||
TALC | ORAL | POWDER, FOR SUSPENSION | 14807966 | 7SEV7J4R1U | 735mg | ||
TALC | ORAL | SUSPENSION | 14807966 | 7SEV7J4R1U | 175mg | ||
TALC | ORAL | SUSPENSION, EXTENDED RELEASE | 14807966 | 7SEV7J4R1U | 46mg | ||
TALC | ORAL | SYRUP | 14807966 | 7SEV7J4R1U | NA | ||
TALC | ORAL | TABLET | 14807966 | 7SEV7J4R1U | 1000mg | ||
TALC | ORAL | TABLET, CHEWABLE | 14807966 | 7SEV7J4R1U | 202mg | ||
TALC | ORAL | TABLET, CHEWABLE, EXTENDED RELEASE | 14807966 | 7SEV7J4R1U | 18mg | ||
TALC | ORAL | TABLET, COATED | 14807966 | 7SEV7J4R1U | 320.75mg | ||
TALC | ORAL | TABLET, DELAYED RELEASE | 14807966 | 7SEV7J4R1U | 349mg | ||
TALC | ORAL | TABLET, DELAYED RELEASE PARTICLES | 14807966 | 7SEV7J4R1U | 56mg | ||
TALC | ORAL | TABLET, EXTENDED RELEASE | 14807966 | 7SEV7J4R1U | 300mg | ||
TALC | ORAL | TABLET, FILM COATED | 14807966 | 7SEV7J4R1U | 182mg | ||
TALC | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 14807966 | 7SEV7J4R1U | 60mg | ||
TALC | ORAL | TABLET, FOR SUSPENSION | 14807966 | 7SEV7J4R1U | 2mg | ||
TALC | ORAL | TABLET, MULTILAYER, EXTENDED RELEASE | 14807966 | 7SEV7J4R1U | 18mg | ||
TALC | ORAL | TABLET, ORALLY DISINTEGRATING | 14807966 | 7SEV7J4R1U | 58mg | ||
TALC | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 14807966 | 7SEV7J4R1U | 357mg | ||
TALC | ORAL | TABLET, SUGAR COATED | 14807966 | 7SEV7J4R1U | NA | ||
TALC | RECTAL | TABLET | 14807966 | 7SEV7J4R1U | 32.4mg | ||
TALC | SUBLINGUAL | TABLET | 14807966 | 7SEV7J4R1U | 32.4mg | ||
TALC | TOPICAL | OINTMENT | 14807966 | 7SEV7J4R1U | 74.6%w/w | ||
TALC | TOPICAL | POWDER | 14807966 | 7SEV7J4R1U | 9235mg | ||
TARTARIC ACID | INTRAMUSCULAR | INJECTION | 87694 | W4888I119H | 11mg | ||
TARTARIC ACID | INTRAMUSCULAR | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 87694 | W4888I119H | 11mg | ||
TARTARIC ACID | INTRAMUSCULAR | INJECTION, SOLUTION | 87694 | W4888I119H | 0.23%w/v | ||
TARTARIC ACID | INTRAVENOUS | INJECTION | 87694 | W4888I119H | 20mg | ||
TARTARIC ACID | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 87694 | W4888I119H | 20mg | ||
TARTARIC ACID | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 87694 | W4888I119H | 20mg | ||
TARTARIC ACID | INTRAVENOUS | INJECTION, SOLUTION | 87694 | W4888I119H | 20mg | Y | |
TARTARIC ACID | INTRAVENOUS | SOLUTION, CONCENTRATE | 87694 | W4888I119H | 20mg | Y | |
TARTARIC ACID | ORAL | CAPSULE | 87694 | W4888I119H | 460mg | ||
TARTARIC ACID | ORAL | CAPSULE, EXTENDED RELEASE | 87694 | W4888I119H | 1325mg | ||
TARTARIC ACID | ORAL | PELLET | 87694 | W4888I119H | 354mg | ||
TARTARIC ACID | ORAL | POWDER, FOR SOLUTION | 87694 | W4888I119H | 270mg | ||
TARTARIC ACID | ORAL | SOLUTION | 87694 | W4888I119H | 270mg | ||
TARTARIC ACID | ORAL | SUSPENSION | 87694 | W4888I119H | 40mg | ||
TARTARIC ACID | ORAL | TABLET | 87694 | W4888I119H | 40mg | ||
TARTARIC ACID | ORAL | TABLET, COATED | 87694 | W4888I119H | 10mg | ||
TARTARIC ACID | ORAL | TABLET, EXTENDED RELEASE | 87694 | W4888I119H | 96mg | ||
TARTARIC ACID | ORAL | TABLET, FILM COATED | 87694 | W4888I119H | 30mg | ||
TARTARIC ACID | ORAL | TABLET, FOR SUSPENSION | 87694 | W4888I119H | 28mg | ||
TARTARIC ACID | ORAL | TABLET, ORALLY DISINTEGRATING | 87694 | W4888I119H | 45mg | ||
TARTARIC ACID | RECTAL | SUPPOSITORY | 133379 | W4888I119H | 43mg | ||
TARTARIC ACID | SUBCUTANEOUS | INJECTION, SOLUTION | 87694 | W4888I119H | 3mg | ||
TARTARIC ACID | SUBLINGUAL | TABLET | 133379 | W4888I119H | NA | ||
TARTARIC ACID | TOPICAL | SYSTEM | 87694 | W4888I119H | 349mg | ||
TEA TREE OIL | TOPICAL | SHAMPOO | 68647734 | VIF565UC2G | 0.01%w/w | ||
TEGACID | TOPICAL | CREAM | 8049078 | NA | 16%w/w | ||
TENOX | TOPICAL | CREAM | NA | 0.03%w/w | |||
TENOX | TOPICAL | OINTMENT | NA | 0.03%w/w | |||
TENOX-2 | TOPICAL | OINTMENT | NA | 0.03%w/w | |||
TERPENE RESIN | ORAL | CAPSULE | 9003741 | GR35AH6YDN | NA | ||
TERPENE RESIN | ORAL | CAPSULE, EXTENDED RELEASE | 9003741 | GR35AH6YDN | NA | ||
TERT-BUTYL ALCOHOL | TOPICAL | GEL | 75650 | MD83SFE959 | 0.12%w/w | ||
TERT-BUTYLHYDROQUINONE | VAGINAL | CREAM | 1948330 | C12674942B | 1mg | ||
TETRACHLOROETHYLENE | ORAL | TABLET, DELAYED RELEASE | 127184 | TJ904HH8SN | 702mg | ||
TETRAXETAN | INTRAVENOUS | INJECTION, SOLUTION | 60239181 | 1HTE449DGZ | 8mg | ||
THIMEROSAL | AURICULAR (OTIC) | DROPS | 54648 | 2225PI3MOV | NA | ||
THIMEROSAL | AURICULAR (OTIC) | SOLUTION | 54648 | 2225PI3MOV | 0.01%w/w | ||
THIMEROSAL | AURICULAR (OTIC) | SUSPENSION | 54648 | 2225PI3MOV | 0.01%w/v | ||
THIMEROSAL | INTRAMUSCULAR | INJECTION | 54648 | 2225PI3MOV | 0.3mg | ||
THIMEROSAL | INTRAVENOUS | INJECTION | 54648 | 2225PI3MOV | 0.3mg | ||
THIMEROSAL | NASAL | DROPS | 54648 | 2225PI3MOV | 0.01mg/1ml | ||
THIMEROSAL | NASAL | SOLUTION | 54648 | 2225PI3MOV | 0.01mg/1ml | ||
THIMEROSAL | OPHTHALMIC | SOLUTION | 54648 | 2225PI3MOV | 0.01%w/v | ||
THIMEROSAL | OPHTHALMIC | SOLUTION/ DROPS | 54648 | 2225PI3MOV | NA | ||
THIMEROSAL | OPHTHALMIC | SUSPENSION | 54648 | 2225PI3MOV | NA | ||
THIMEROSAL | OPHTHALMIC | SUSPENSION/ DROPS | 54648 | 2225PI3MOV | 1%v/v | ||
THIMEROSAL | SUBCUTANEOUS | INJECTION | 54648 | 2225PI3MOV | NA | ||
THIMEROSAL | TOPICAL | CREAM | 54648 | 2225PI3MOV | NA | ||
THIMEROSAL | TOPICAL | LOTION | 54648 | 2225PI3MOV | NA | ||
THREONINE | INTRAVENOUS | INJECTION | 72195 | 2ZD004190S | 0.45%w/v | ||
THREONINE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 72195 | 2ZD004190S | 160mg | ||
THREONINE | INTRAVENOUS | INJECTION, SOLUTION | 72195 | 2ZD004190S | 0.12%w/v | ||
THYME OIL | TOPICAL | OINTMENT | 8007463 | 2UK410MY6B | 0.1%w/w | ||
THYMOL | ORAL | POWDER, FOR SOLUTION | 89838 | 3J50XA376E | NA | ||
THYMOL | RESPIRATORY (INHALATION) | LIQUID | 89838 | 3J50XA376E | 0.01%w/w | ||
TIMING SOLUTION CLEAR N-7 | ORAL | CAPSULE, EXTENDED RELEASE | NA | 26.2mg | |||
TITANIUM DIOXIDE | BUCCAL | FILM | 13463677 | 15FIX9V2JP | 3mg | ||
TITANIUM DIOXIDE | BUCCAL | FILM, SOLUBLE | 13463677 | 15FIX9V2JP | 11mg | ||
TITANIUM DIOXIDE | BUCCAL | GUM, CHEWING | 13463677 | 15FIX9V2JP | 182mg | ||
TITANIUM DIOXIDE | DENTAL | PASTE | 13463677 | 15FIX9V2JP | 0.5%w/w | ||
TITANIUM DIOXIDE | DENTAL | PASTE, DENTIFRICE | 13463677 | 15FIX9V2JP | 0.4%w/w | ||
TITANIUM DIOXIDE | INTRAUTERINE | SUPPOSITORY, EXTENDED RELEASE | 13463677 | 15FIX9V2JP | 1mg | ||
TITANIUM DIOXIDE | OPHTHALMIC | INSERT, EXTENDED RELEASE | 13463677 | 15FIX9V2JP | 0.4mg | ||
TITANIUM DIOXIDE | ORAL | CAPSULE | 13463677 | 15FIX9V2JP | 70mg | ||
TITANIUM DIOXIDE | ORAL | CAPSULE, COATED | 13463677 | 15FIX9V2JP | 17mg | ||
TITANIUM DIOXIDE | ORAL | CAPSULE, COATED PELLETS | 13463677 | 15FIX9V2JP | 4.4mg | ||
TITANIUM DIOXIDE | ORAL | CAPSULE, COATED, EXTENDED RELEASE | 13463677 | 15FIX9V2JP | NA | ||
TITANIUM DIOXIDE | ORAL | CAPSULE, DELAYED RELEASE | 13463677 | 15FIX9V2JP | 55mg | ||
TITANIUM DIOXIDE | ORAL | CAPSULE, DELAYED RELEASE PELLETS | 13463677 | 15FIX9V2JP | 24mg | ||
TITANIUM DIOXIDE | ORAL | CAPSULE, EXTENDED RELEASE | 13463677 | 15FIX9V2JP | 67mg | ||
TITANIUM DIOXIDE | ORAL | CAPSULE, LIQUID FILLED | 13463677 | 15FIX9V2JP | 12mg | ||
TITANIUM DIOXIDE | ORAL | DROPS | 13463677 | 15FIX9V2JP | NA | ||
TITANIUM DIOXIDE | ORAL | FILM, SOLUBLE | 13463677 | 15FIX9V2JP | 2mg | ||
TITANIUM DIOXIDE | ORAL | GRANULE, FOR SUSPENSION | 13463677 | 15FIX9V2JP | 143mg | ||
TITANIUM DIOXIDE | ORAL | POWDER | 13463677 | 15FIX9V2JP | 2mg | ||
TITANIUM DIOXIDE | ORAL | POWDER, FOR SUSPENSION | 13463677 | 15FIX9V2JP | 297mg | ||
TITANIUM DIOXIDE | ORAL | SUSPENSION | 13463677 | 15FIX9V2JP | 113mg | ||
TITANIUM DIOXIDE | ORAL | TABLET | 13463677 | 15FIX9V2JP | 120mg | ||
TITANIUM DIOXIDE | ORAL | TABLET, COATED | 13463677 | 15FIX9V2JP | 49mg | ||
TITANIUM DIOXIDE | ORAL | TABLET, DELAYED RELEASE | 13463677 | 15FIX9V2JP | 33mg | ||
TITANIUM DIOXIDE | ORAL | TABLET, EXTENDED RELEASE | 13463677 | 15FIX9V2JP | 90mg | ||
TITANIUM DIOXIDE | ORAL | TABLET, FILM COATED | 13463677 | 15FIX9V2JP | 36mg | ||
TITANIUM DIOXIDE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 13463677 | 15FIX9V2JP | 11mg | ||
TITANIUM DIOXIDE | ORAL | TABLET, ORALLY DISINTEGRATING | 13463677 | 15FIX9V2JP | 6mg | ||
TITANIUM DIOXIDE | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 13463677 | 15FIX9V2JP | 42mg | ||
TITANIUM DIOXIDE | RESPIRATORY (INHALATION) | CAPSULE | 13463677 | 15FIX9V2JP | NA | ||
TITANIUM DIOXIDE | RESPIRATORY (INHALATION) | POWDER | 13463677 | 15FIX9V2JP | 2mg | ||
TITANIUM DIOXIDE | TOPICAL | CREAM | 13463677 | 15FIX9V2JP | 80mg | ||
TITANIUM DIOXIDE | TOPICAL | GEL | 13463677 | 15FIX9V2JP | 0.06%w/w | ||
TITANIUM DIOXIDE | TOPICAL | LOTION | 13463677 | 15FIX9V2JP | NA | ||
TITANIUM DIOXIDE | TOPICAL | OINTMENT | 13463677 | 15FIX9V2JP | 5%w/w | ||
TITANIUM DIOXIDE | TOPICAL | SHAMPOO, SUSPENSION | 13463677 | 15FIX9V2JP | 3%w/v | ||
TITANIUM DIOXIDE | TOPICAL | SOAP | 13463677 | 15FIX9V2JP | 1%w/w | ||
TITANIUM DIOXIDE | TOPICAL | SYSTEM | 13463677 | 15FIX9V2JP | 420mg | ||
TITANIUM DIOXIDE | TRANSDERMAL | FILM, EXTENDED RELEASE | 13463677 | 15FIX9V2JP | NA | ||
TITANIUM DIOXIDE | VAGINAL | SUPPOSITORY | 13463677 | 15FIX9V2JP | NA | ||
TOCOPHEROL | INTRAVENOUS | INJECTION, EMULSION | 1406662 | R0ZB2556P8 | 0.02%w/v | ||
TOCOPHEROL | ORAL | CAPSULE | 1406662 | R0ZB2556P8 | NA | ||
TOCOPHEROL | ORAL | CAPSULE, COATED | 1406662 | R0ZB2556P8 | 0.25mg | ||
TOCOPHEROL | ORAL | TABLET | 1406662 | R0ZB2556P8 | 0.08mg | ||
TOCOPHEROL | TOPICAL | CREAM | 1406662 | R0ZB2556P8 | NA | ||
TRAGACANTH | BUCCAL | TABLET | 9000651 | 2944357O2O | 5mg | ||
TRAGACANTH | ORAL | POWDER, FOR SUSPENSION | 9000651 | 2944357O2O | 60mg/1ml | ||
TRAGACANTH | ORAL | SUSPENSION | 9000651 | 2944357O2O | 130mg | ||
TRAGACANTH | ORAL | SUSPENSION, EXTENDED RELEASE | 9000651 | 2944357O2O | 70mg | ||
TRAGACANTH | ORAL | TABLET | 9000651 | 2944357O2O | 12mg | ||
TRAGACANTH | ORAL | TABLET, COATED | 9000651 | 2944357O2O | 7.5mg | ||
TRAGACANTH | ORAL | TABLET, DELAYED RELEASE | 9000651 | 2944357O2O | NA | ||
TRAGACANTH | ORAL | TABLET, EXTENDED RELEASE | 9000651 | 2944357O2O | 7mg | ||
TRAGACANTH | ORAL | WAFER | 9000651 | 2944357O2O | 32mg | ||
TRAGACANTH | SUBLINGUAL | TABLET | 9000651 | 2944357O2O | 5mg | ||
TRAGACANTH | TOPICAL | JELLY | 9000651 | 2944357O2O | NA | ||
TREHALOSE DIHYDRATE | INTRADERMAL | INJECTION, POWDER, FOR SOLUTION | 6138234 | 7YIN7J07X4 | 4mg | ||
TREHALOSE DIHYDRATE | SUBCUTANEOUS | INJECTION | 6138234 | 7YIN7J07X4 | 11mg | ||
TREHALOSE DIHYDRATE | SUBCUTANEOUS | INJECTION, POWDER, FOR SOLUTION | 6138234 | 7YIN7J07X4 | 4mg | ||
TRIACETIN | ORAL | CAPSULE | 102761 | XHX3C3X673 | 13mg | ||
TRIACETIN | ORAL | CAPSULE, COATED PELLETS | 102761 | XHX3C3X673 | 1.21mg | ||
TRIACETIN | ORAL | CAPSULE, DELAYED RELEASE | 102761 | XHX3C3X673 | 5.1mg | ||
TRIACETIN | ORAL | CAPSULE, EXTENDED RELEASE | 102761 | XHX3C3X673 | 467mg | ||
TRIACETIN | ORAL | CONCENTRATE | 102761 | XHX3C3X673 | 250mg | Y | |
TRIACETIN | ORAL | POWDER, FOR SUSPENSION | 102761 | XHX3C3X673 | 12mg | ||
TRIACETIN | ORAL | SUSPENSION | 102761 | XHX3C3X673 | 7mg | ||
TRIACETIN | ORAL | SUSPENSION, EXTENDED RELEASE | 102761 | XHX3C3X673 | 4mg | ||
TRIACETIN | ORAL | TABLET | 102761 | XHX3C3X673 | 208mg | ||
TRIACETIN | ORAL | TABLET, CHEWABLE, EXTENDED RELEASE | 102761 | XHX3C3X673 | 2mg | ||
TRIACETIN | ORAL | TABLET, COATED | 102761 | XHX3C3X673 | 1mg | ||
TRIACETIN | ORAL | TABLET, DELAYED RELEASE | 102761 | XHX3C3X673 | 7mg | ||
TRIACETIN | ORAL | TABLET, EXTENDED RELEASE | 102761 | XHX3C3X673 | 26mg | ||
TRIACETIN | ORAL | TABLET, FILM COATED | 102761 | XHX3C3X673 | 15.12mg | ||
TRIACETIN | TRANSDERMAL | SYSTEM | 102761 | XHX3C3X673 | 22.1mg | ||
TRIBASIC CALCIUM PHOSPHATE | BUCCAL | TABLET | 1306065 | 91D9GV0Z28 | 99.2mg | ||
TRIBASIC CALCIUM PHOSPHATE | ORAL | CAPSULE | 1306065 | 91D9GV0Z28 | 176mg | Y | |
TRIBASIC CALCIUM PHOSPHATE | ORAL | CAPSULE, EXTENDED RELEASE | 1306065 | 91D9GV0Z28 | 32.73mg | ||
TRIBASIC CALCIUM PHOSPHATE | ORAL | TABLET | 1306065 | 91D9GV0Z28 | 330mg | ||
TRIBASIC CALCIUM PHOSPHATE | ORAL | TABLET, CHEWABLE | 1306065 | 91D9GV0Z28 | 130mg | ||
TRIBASIC CALCIUM PHOSPHATE | ORAL | TABLET, COATED | 1306065 | 91D9GV0Z28 | 40mg | ||
TRIBASIC CALCIUM PHOSPHATE | ORAL | TABLET, DELAYED RELEASE | 1306065 | 91D9GV0Z28 | 333.3mg | ||
TRIBASIC CALCIUM PHOSPHATE | ORAL | TABLET, EXTENDED RELEASE | 1306065 | 91D9GV0Z28 | 750mg | ||
TRIBASIC CALCIUM PHOSPHATE | ORAL | TABLET, FILM COATED | 1306065 | 91D9GV0Z28 | 21.8mg | ||
TRIBASIC CALCIUM PHOSPHATE | SUBLINGUAL | TABLET | 1306065 | 91D9GV0Z28 | 99.2mg | ||
TRICAPRILIN | EPIDURAL | INJECTION, SUSPENSION, LIPOSOMAL | 538238 | 6P92858988 | 1mg | Y | |
TRICAPRILIN | INFILTRATION | INJECTABLE, LIPOSOMAL | 538238 | 6P92858988 | 0.2%w/v | ||
TRICAPRILIN | ORAL | TABLET, EXTENDED RELEASE | 538238 | 6P92858988 | 0.45mg | ||
TRICHLOROETHANE | ORAL | TABLET | 71556 | 113C650IR1 | NA | ||
TRICHLOROETHANE | ORAL | TABLET, COATED | 71556 | 113C650IR1 | NA | ||
TRICHLOROMONOFLUOROMETHANE | ORAL | AEROSOL, METERED | 75694 | 990TYB331R | 650mg/1ml | ||
TRICHLOROMONOFLUOROMETHANE | RESPIRATORY (INHALATION) | AEROSOL, METERED | 75694 | 990TYB331R | 27.88%w/w | ||
TRICHLOROMONOFLUOROMETHANE | RESPIRATORY (INHALATION) | AEROSOL, SPRAY | 75694 | 990TYB331R | 24.4%w/w | ||
TRICHLOROMONOFLUOROMETHANE | TOPICAL | AEROSOL, POWDER | 75694 | 990TYB331R | NA | ||
TRICHLOROMONOFLUOROMETHANE | TOPICAL | AEROSOL, SPRAY | 75694 | 990TYB331R | 74%w/w | ||
TRIDECETH-10 | TOPICAL | SOLUTION | 24938918 | G624N6MSBA | 4%w/w | ||
TRIETHANOLAMINE LAURYL SULFATE | TOPICAL | CREAM | 139968 | E8458C1KAA | 0.13%w/w | ||
TRIETHANOLAMINE LAURYL SULFATE | TOPICAL | EMULSION | 139968 | E8458C1KAA | 10.78%w/w | ||
TRIETHANOLAMINE LAURYL SULFATE | TOPICAL | SHAMPOO | 139968 | E8458C1KAA | 75.3%w/v | ||
TRIETHYL CITRATE | INTRAMUSCULAR | INJECTION, POWDER, FOR SUSPENSION | 77930 | 8Z96QXD6UM | 10mg | ||
TRIETHYL CITRATE | ORAL | CAPSULE | 77930 | 8Z96QXD6UM | 32mg | ||
TRIETHYL CITRATE | ORAL | CAPSULE, COATED | 77930 | 8Z96QXD6UM | 7mg | ||
TRIETHYL CITRATE | ORAL | CAPSULE, COATED PELLETS | 77930 | 8Z96QXD6UM | 9.16mg | ||
TRIETHYL CITRATE | ORAL | CAPSULE, COATED, EXTENDED RELEASE | 77930 | 8Z96QXD6UM | 7mg | ||
TRIETHYL CITRATE | ORAL | CAPSULE, DELAYED RELEASE | 77930 | 8Z96QXD6UM | 68mg | ||
TRIETHYL CITRATE | ORAL | CAPSULE, DELAYED RELEASE PELLETS | 77930 | 8Z96QXD6UM | 54mg | ||
TRIETHYL CITRATE | ORAL | CAPSULE, EXTENDED RELEASE | 77930 | 8Z96QXD6UM | 129mg | ||
TRIETHYL CITRATE | ORAL | GRANULE, FOR SUSPENSION | 77930 | 8Z96QXD6UM | 64mg | ||
TRIETHYL CITRATE | ORAL | SUSPENSION | 77930 | 8Z96QXD6UM | 38mg | ||
TRIETHYL CITRATE | ORAL | SUSPENSION, EXTENDED RELEASE | 77930 | 8Z96QXD6UM | 5mg | ||
TRIETHYL CITRATE | ORAL | TABLET | 77930 | 8Z96QXD6UM | 52mg | ||
TRIETHYL CITRATE | ORAL | TABLET, CHEWABLE | 77930 | 8Z96QXD6UM | 34mg | ||
TRIETHYL CITRATE | ORAL | TABLET, DELAYED RELEASE | 77930 | 8Z96QXD6UM | 120mg | ||
TRIETHYL CITRATE | ORAL | TABLET, EXTENDED RELEASE | 77930 | 8Z96QXD6UM | 160mg | ||
TRIETHYL CITRATE | ORAL | TABLET, FILM COATED | 77930 | 8Z96QXD6UM | 3mg | ||
TRIETHYL CITRATE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 77930 | 8Z96QXD6UM | 1mg | ||
TRIETHYL CITRATE | ORAL | TABLET, ORALLY DISINTEGRATING | 77930 | 8Z96QXD6UM | 17mg | ||
TRIETHYL CITRATE | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 77930 | 8Z96QXD6UM | 100mg | ||
TRIHYDROXYSTEARIN | TOPICAL | CREAM | 139446 | 06YD7896S3 | NA | ||
TRIHYDROXYSTEARIN | TOPICAL | OINTMENT | 139446 | 06YD7896S3 | 3%w/w | ||
TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (35/65 W/W; 50000000 PA.S) | TRANSDERMAL | FILM, EXTENDED RELEASE | 0A6MDS9SLT | 171.17mg | |||
TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (35/65 W/W; 50000000 PA.S) | TRANSDERMAL | SYSTEM | 0A6MDS9SLT | 45mg | |||
TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 5000000 PA.S) | TOPICAL | SYSTEM | 9N5G1G3D3H | 89mg | |||
TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 5000000 PA.S) | TRANSDERMAL | FILM, EXTENDED RELEASE | 9N5G1G3D3H | 1669mg | |||
TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (45/55 W/W; 100000 PA.S) | TOPICAL | SYSTEM | 5VBE2X0WG0 | 89mg | |||
TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (45/55 W/W; 100000 PA.S) | TRANSDERMAL | FILM, EXTENDED RELEASE | 5VBE2X0WG0 | 704mg | |||
TRISODIUM CITRATE DIHYDRATE | INTRA-ARTICULAR | INJECTION, SOLUTION | 6132043 | B22547B95K | 25mg | ||
TRISODIUM CITRATE DIHYDRATE | INTRACARDIAC | INJECTION | 6132043 | B22547B95K | 21mg | ||
TRISODIUM CITRATE DIHYDRATE | INTRAMUSCULAR | INJECTION | 6132043 | B22547B95K | 3480mg | ||
TRISODIUM CITRATE DIHYDRATE | INTRAMUSCULAR | INJECTION, SOLUTION | 6132043 | B22547B95K | 1188mg | ||
TRISODIUM CITRATE DIHYDRATE | INTRAMUSCULAR | SOLUTION | 6132043 | B22547B95K | 0.03%w/v | ||
TRISODIUM CITRATE DIHYDRATE | INTRAOCULAR | INJECTION, SOLUTION, CONCENTRATE | 6132043 | B22547B95K | 5.48mg | ||
TRISODIUM CITRATE DIHYDRATE | INTRAOCULAR | SOLUTION | 6132043 | B22547B95K | 27mg | ||
TRISODIUM CITRATE DIHYDRATE | INTRAVENOUS | INJECTION | 6132043 | B22547B95K | 3480mg | ||
TRISODIUM CITRATE DIHYDRATE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 6132043 | B22547B95K | 235.2mg | ||
TRISODIUM CITRATE DIHYDRATE | INTRAVENOUS | INJECTION, SOLUTION | 6132043 | B22547B95K | 1188mg | ||
TRISODIUM CITRATE DIHYDRATE | INTRAVENOUS | SOLUTION | 6132043 | B22547B95K | 41mg | ||
TRISODIUM CITRATE DIHYDRATE | INTRAVITREAL | INJECTION, SUSPENSION | 6132043 | B22547B95K | 0.17%w/v | ||
TRISODIUM CITRATE DIHYDRATE | IRRIGATION | INJECTION, SOLUTION, CONCENTRATE | 6132043 | B22547B95K | 0.55%w/v | ||
TRISODIUM CITRATE DIHYDRATE | NASAL | SPRAY | 6132043 | B22547B95K | 9mg | ||
TRISODIUM CITRATE DIHYDRATE | NASAL | SPRAY, METERED | 6132043 | B22547B95K | 1mg | ||
TRISODIUM CITRATE DIHYDRATE | OPHTHALMIC | SOLUTION | 6132043 | B22547B95K | 0.45%w/v | ||
TRISODIUM CITRATE DIHYDRATE | OPHTHALMIC | SOLUTION/ DROPS | 6132043 | B22547B95K | 1mg | ||
TRISODIUM CITRATE DIHYDRATE | OPHTHALMIC | SUSPENSION/ DROPS | 6132043 | B22547B95K | 1mg | ||
TRISODIUM CITRATE DIHYDRATE | ORAL | CAPSULE | 6132043 | B22547B95K | 35mg | ||
TRISODIUM CITRATE DIHYDRATE | ORAL | ELIXIR | 6132043 | B22547B95K | 0.47mg/1ml | ||
TRISODIUM CITRATE DIHYDRATE | ORAL | GRANULE, FOR SUSPENSION | 6132043 | B22547B95K | 4950mg | ||
TRISODIUM CITRATE DIHYDRATE | ORAL | POWDER, FOR SUSPENSION | 6132043 | B22547B95K | 5010mg | ||
TRISODIUM CITRATE DIHYDRATE | ORAL | SOLUTION | 6132043 | B22547B95K | 773mg | ||
TRISODIUM CITRATE DIHYDRATE | ORAL | SUSPENSION | 6132043 | B22547B95K | 5013mg | ||
TRISODIUM CITRATE DIHYDRATE | ORAL | SYRUP | 6132043 | B22547B95K | 705mg | ||
TRISODIUM CITRATE DIHYDRATE | ORAL | TABLET | 6132043 | B22547B95K | 896mg | ||
TRISODIUM CITRATE DIHYDRATE | ORAL | TABLET, CHEWABLE | 6132043 | B22547B95K | 14mg | ||
TRISODIUM CITRATE DIHYDRATE | ORAL | TABLET, DELAYED RELEASE | 6132043 | B22547B95K | 640mg | ||
TRISODIUM CITRATE DIHYDRATE | ORAL | TABLET, EXTENDED RELEASE | 6132043 | B22547B95K | 300mg | ||
TRISODIUM CITRATE DIHYDRATE | ORAL | TABLET, FILM COATED | 6132043 | B22547B95K | 200mg | ||
TRISODIUM CITRATE DIHYDRATE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 6132043 | B22547B95K | 200mg | ||
TRISODIUM CITRATE DIHYDRATE | PARENTERAL | INJECTION | 6132043 | B22547B95K | 0.48%w/v | ||
TRISODIUM CITRATE DIHYDRATE | RESPIRATORY (INHALATION) | POWDER | 6132043 | B22547B95K | 17mg | ||
TRISODIUM CITRATE DIHYDRATE | RESPIRATORY (INHALATION) | SOLUTION | 6132043 | B22547B95K | 24mg | ||
TRISODIUM CITRATE DIHYDRATE | RESPIRATORY (INHALATION) | SUSPENSION | 6132043 | B22547B95K | 0.05%w/v | ||
TRISODIUM CITRATE DIHYDRATE | SUBCUTANEOUS | INJECTION | 6132043 | B22547B95K | 26mg | ||
TRISODIUM CITRATE DIHYDRATE | SUBCUTANEOUS | INJECTION, SOLUTION | 6132043 | B22547B95K | 28mg | ||
TRISODIUM CITRATE DIHYDRATE | SUBLINGUAL | FILM | 6132043 | B22547B95K | 7mg | ||
TRISODIUM CITRATE DIHYDRATE | SUBLINGUAL | TABLET | 6132043 | B22547B95K | 51mg | ||
TRISODIUM CITRATE DIHYDRATE | TOPICAL | CLOTH | 6132043 | B22547B95K | 2mg | ||
TRISODIUM CITRATE DIHYDRATE | TOPICAL | CREAM | 6132043 | B22547B95K | 0.3%w/w | ||
TRISODIUM CITRATE DIHYDRATE | TOPICAL | GEL | 6132043 | B22547B95K | 0.18%w/w | ||
TRISODIUM CITRATE DIHYDRATE | TOPICAL | LOTION | 6132043 | B22547B95K | 0.32%w/w | ||
TRISODIUM CITRATE DIHYDRATE | TOPICAL | SHAMPOO | 6132043 | B22547B95K | 2.6%w/w | ||
TRISODIUM CITRATE DIHYDRATE | TOPICAL | SOLUTION | 6132043 | B22547B95K | 186mg | ||
TRISODIUM HEDTA | TOPICAL | SOAP | 139899 | K3E0U7O8KI | 0.4%w/w | ||
TRISODIUM HEDTA | TOPICAL | SOLUTION | 139899 | K3E0U7O8KI | 0.4%w/w | ||
TROLAMINE | INTRAVENOUS | INJECTION, POWDER, FOR SUSPENSION | 102716 | 9O3K93S3TK | 0.02%w/v | ||
TROLAMINE | NASAL | DROPS | 102716 | 9O3K93S3TK | NA | ||
TROLAMINE | NASAL | SOLUTION | 102716 | 9O3K93S3TK | NA | ||
TROLAMINE | NASAL | SPRAY | 102716 | 9O3K93S3TK | NA | ||
TROLAMINE | RECTAL | AEROSOL, METERED | 102716 | 9O3K93S3TK | ADJ PH | ||
TROLAMINE | TOPICAL | AEROSOL, FOAM | 102716 | 9O3K93S3TK | 2.6%w/w | ||
TROLAMINE | TOPICAL | CREAM | 102716 | 9O3K93S3TK | 1%w/w | ||
TROLAMINE | TOPICAL | CREAM, AUGMENTED | 102716 | 9O3K93S3TK | 20mg | ||
TROLAMINE | TOPICAL | EMULSION | 102716 | 9O3K93S3TK | 0.5%w/w | ||
TROLAMINE | TOPICAL | GEL | 102716 | 9O3K93S3TK | 4mg | ||
TROLAMINE | TOPICAL | GEL, METERED | 102716 | 9O3K93S3TK | 19mg | ||
TROLAMINE | TOPICAL | LIQUID | 102716 | 9O3K93S3TK | NA | ||
TROLAMINE | TOPICAL | LOTION | 102716 | 9O3K93S3TK | 360mg | Y | |
TROLAMINE | TOPICAL | POWDER | 102716 | 9O3K93S3TK | 0.02mg/mg | ||
TROLAMINE | TOPICAL | SHAMPOO | 102716 | 9O3K93S3TK | 3.7%w/w | ||
TROLAMINE | TOPICAL | SOAP | 102716 | 9O3K93S3TK | 0.08%w/w | ||
TROLAMINE | TOPICAL | SOLUTION | 102716 | 9O3K93S3TK | NA | ||
TROLAMINE | TOPICAL | SPONGE | 102716 | 9O3K93S3TK | 11%w/w | ||
TROLAMINE | TRANSDERMAL | GEL | 102716 | 9O3K93S3TK | 1mg | ||
TROLAMINE | TRANSDERMAL | GEL, METERED | 102716 | 9O3K93S3TK | 1%w/w | ||
TROLAMINE | VAGINAL | AEROSOL, FOAM | 102716 | 9O3K93S3TK | 2%w/w | ||
TROLAMINE | VAGINAL | CREAM | 102716 | 9O3K93S3TK | 0.75%w/w | ||
TROMETHAMINE | ENDOTRACHEAL | SUSPENSION | 77861 | 023C2WHX2V | 2.42mg | ||
TROMETHAMINE | INTRA-ARTERIAL | INJECTION | 77861 | 023C2WHX2V | 562mg | ||
TROMETHAMINE | INTRA-ARTERIAL | INJECTION, SOLUTION | 77861 | 023C2WHX2V | 300mg | ||
TROMETHAMINE | INTRAMUSCULAR | INJECTION | 77861 | 023C2WHX2V | 437mg | ||
TROMETHAMINE | INTRAMUSCULAR | INJECTION, SOLUTION | 77861 | 023C2WHX2V | 1.21%w/v | ||
TROMETHAMINE | INTRATHECAL | SOLUTION | 77861 | 023C2WHX2V | 0.12%w/v | ||
TROMETHAMINE | INTRATYMPANIC | SUSPENSION | 77861 | 023C2WHX2V | 0.56%w/w | ||
TROMETHAMINE | INTRAVASCULAR | INJECTION, SOLUTION | 77861 | 023C2WHX2V | 225mg | ||
TROMETHAMINE | INTRAVASCULAR | SOLUTION | 77861 | 023C2WHX2V | 0.12%w/v | ||
TROMETHAMINE | INTRAVENOUS | INJECTION | 77861 | 023C2WHX2V | 1134mg | ||
TROMETHAMINE | INTRAVENOUS | INJECTION, POWDER, FOR SUSPENSION | 77861 | 023C2WHX2V | 6.06mg | ||
TROMETHAMINE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 77861 | 023C2WHX2V | 0.24%w/v | ||
TROMETHAMINE | INTRAVENOUS | INJECTION, SOLUTION | 77861 | 023C2WHX2V | 300mg | ||
TROMETHAMINE | INTRAVENOUS | SOLUTION | 77861 | 023C2WHX2V | 0.12%w/v | ||
TROMETHAMINE | OPHTHALMIC | SOLUTION | 77861 | 023C2WHX2V | 0.75%w/v | ||
TROMETHAMINE | OPHTHALMIC | SOLUTION, GEL FORMING / DROPS | 77861 | 023C2WHX2V | 1mg | Y | |
TROMETHAMINE | OPHTHALMIC | SOLUTION, GEL FORMING, EXTENDED RELEASE | 77861 | 023C2WHX2V | 0.8%w/w | ||
TROMETHAMINE | OPHTHALMIC | SOLUTION/ DROPS | 77861 | 023C2WHX2V | 0.8%w/v | ||
TROMETHAMINE | OPHTHALMIC | SUSPENSION/ DROPS | 77861 | 023C2WHX2V | ADJ PH | ||
TROMETHAMINE | ORAL | CAPSULE | 77861 | 023C2WHX2V | 30mg | ||
TROMETHAMINE | ORAL | SOLUTION | 77861 | 023C2WHX2V | 1.21mg/1ml | ||
TROMETHAMINE | ORAL | TABLET | 77861 | 023C2WHX2V | 30mg | Y | |
TROMETHAMINE | RECTAL | SOLUTION | 77861 | 023C2WHX2V | 0.12%w/v | ||
TROMETHAMINE | RESPIRATORY (INHALATION) | SOLUTION | 77861 | 023C2WHX2V | 0.01%w/v | ||
TROMETHAMINE | TOPICAL | GEL | 77861 | 023C2WHX2V | 56mg | ||
TROMETHAMINE | TOPICAL | SOLUTION | 77861 | 023C2WHX2V | 8.4%w/w | ||
TROMETHAMINE | TRANSDERMAL | GEL | 77861 | 023C2WHX2V | 0.1%w/w | ||
TROMETHAMINE | URETHRAL | SOLUTION | 77861 | 023C2WHX2V | 0.12%w/v | ||
TRYPTOPHAN | INTRAVENOUS | INJECTION | 73223 | 8DUH1N11BX | 1.65mg | ||
TRYPTOPHAN | INTRAVENOUS | INJECTION, SOLUTION | 73223 | 8DUH1N11BX | 0.05%w/v | ||
TURPENTINE OIL | RESPIRATORY (INHALATION) | LIQUID | 8006642 | C5H0QJ6V7F | NA | ||
TYLOXAPOL | AURICULAR (OTIC) | SUSPENSION | 25301024 | Y27PUL9H56 | 0.05%w/v | ||
TYLOXAPOL | AURICULAR (OTIC) | SUSPENSION/ DROPS | 25301024 | Y27PUL9H56 | 0.05%w/v | ||
TYLOXAPOL | OPHTHALMIC | GEL | 25301024 | Y27PUL9H56 | 0.05%w/w | ||
TYLOXAPOL | OPHTHALMIC | SOLUTION | 25301024 | Y27PUL9H56 | 3mg | ||
TYLOXAPOL | OPHTHALMIC | SOLUTION/ DROPS | 25301024 | Y27PUL9H56 | 4mg | ||
TYLOXAPOL | OPHTHALMIC | SUSPENSION | 25301024 | Y27PUL9H56 | 7mg | Y | |
TYLOXAPOL | OPHTHALMIC | SUSPENSION/ DROPS | 25301024 | Y27PUL9H56 | 0.3%w/v | ||
TYLOXAPOL | TOPICAL | SUSPENSION/ DROPS | 25301024 | Y27PUL9H56 | 0.03%w/v |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: July 3, 2024
Database Last Updated: July 31, 2024